| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |